Works matching IS 03051870 AND DT 2025 AND VI 52 AND IP 2
Results: 7
Sirt6, Deubiquitinated and Stabilised by USP9X, Takes Essential Actions on the Pathogenesis of Experimental Autoimmune Myasthenia Gravis by Regulating CD4<sup>+</sup> T Cells.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2025, v. 52, n. 2, p. 1, doi. 10.1111/1440-1681.70018
- By:
- Publication type:
- Article
Phillygenin Inhibits PI3K‐Akt–mTOR Signalling Pathway to Prevent bleomycin‐Induced Idiopathic Pulmonary Fibrosis in Mice.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2025, v. 52, n. 2, p. 1, doi. 10.1111/1440-1681.70017
- By:
- Publication type:
- Article
High Salt Exacerbates Myocardial Dysfunction In Vitro and In Vivo by Promoting SIRT1/Nrf2‐Mediated Ferroptosis.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2025, v. 52, n. 2, p. 1, doi. 10.1111/1440-1681.70016
- By:
- Publication type:
- Article
Inhibition of DNA Methyltransferase DNMT1 Reverses Th2 Response Polarisation and Alleviates Allergic Rhinitis.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2025, v. 52, n. 2, p. 1, doi. 10.1111/1440-1681.70015
- By:
- Publication type:
- Article
RETRACTION: Rotenone Restrains the Proliferation, Motility and Epithelial–Mesenchymal Transition of Colon Cancer Cells and the Tumourigenesis in Nude Mice via PI3K/AKT Pathway.
- Published in:
- 2025
- Publication type:
- Correction Notice
Oroxin B Resembles Bisoprolol in Attenuating Beta1‐Adrenergic Receptor Autoantibody‐Induced Atrial Remodelling via the PTEN/AKT/mTOR Signalling Pathway.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2025, v. 52, n. 2, p. 1, doi. 10.1111/1440-1681.70011
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2025, v. 52, n. 2, p. 1, doi. 10.1111/1440-1681.13879
- Publication type:
- Article